Larimar Therapeutics Inc (NASDAQ: LRMR) on Friday, plunged -8.92% from the previous trading day, before settling in for the closing price of $3.81. Within the past 52 weeks, LRMR’s price has moved between $1.61 and $5.37.
Healthcare Sector giant saw their annual sales surged by 50.78% over the last five years. The company achieved an average annual earnings per share of -48.77%. With a float of $47.71 million, this company’s outstanding shares have now reached $85.59 million.
Larimar Therapeutics Inc (LRMR) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Larimar Therapeutics Inc is 44.26%, while institutional ownership is 57.36%. The most recent insider transaction that took place on Jul 31 ’25, was worth 30,000,000. In this transaction Director of this company bought 9,375,000 shares at a rate of $3.20, taking the stock ownership to the 9,538,945 shares.
Larimar Therapeutics Inc (LRMR) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.45 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.32) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -48.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.92% during the next five years compared to 50.78% growth over the previous five years of trading.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
Larimar Therapeutics Inc (LRMR) is currently performing well based on its current performance indicators. A quick ratio of 4.06 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.93, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -1.88 in one year’s time.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
As of the previous 9 days, the stock’s Stochastic %D was 47.44%.
During the past 100 days, Larimar Therapeutics Inc’s (LRMR) raw stochastic average was set at 16.30%, which indicates a significant increase from 16.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was lower than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.73, while its 200-day Moving Average is $3.29. Now, the first resistance to watch is $3.68. This is followed by the second major resistance level at $3.89. The third major resistance level sits at $4.02. If the price goes on to break the first support level at $3.35, it is likely to go to the next support level at $3.22. Should the price break the second support level, the third support level stands at $3.01.
Larimar Therapeutics Inc (NASDAQ: LRMR) Key Stats
Market capitalization of the company is 297.00 million based on 82,778K outstanding shares. Right now, sales total 0 K and income totals -80,600 K. The company made 0 K in profit during its latest quarter, and -47,710 K in sales during its previous quarter.
